Dirk Otto, the general manager of Boehringer Ingelheim Australia and New Zealand, said, “Thousands of Australians face the very real prospect of kidney replacement therapy or serious cardiovascular complications without timely treatment to protect kidney function." …
TGA approves new indication for BI-Lilly alliance SGLT-2 inhibitor
February 22, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
'He will be deeply missed by all who had the pleasure of getting to know him'
August 6, 2025 - - Latest News -
Gilead announces recipients of inaugural GLOWS grants for Indigenous-led HIV and hepatitis projects
August 6, 2025 - - Latest News -
Arrotex Pharmaceuticals welcomes strategic US investment in DBG Health
August 5, 2025 - - Latest News -
'We do what we say we will do', 'lead by example' and 'find a way'
August 5, 2025 - - Latest News -
Novo Nordisk says that without action Australia 'faces a sobering reality' on life expectancy
August 5, 2025 - - Latest News -
A rigged system in which delays are the intent, not the consequence
August 5, 2025 - - Latest News -
TGA halts the promotion of some Vitamin D medicines for bone strength
August 4, 2025 - - Latest News